CY1119731T1 - Διαδικασια για την παρασκευη παραγωγων χολικου οξεος - Google Patents

Διαδικασια για την παρασκευη παραγωγων χολικου οξεος

Info

Publication number
CY1119731T1
CY1119731T1 CY20181100003T CY181100003T CY1119731T1 CY 1119731 T1 CY1119731 T1 CY 1119731T1 CY 20181100003 T CY20181100003 T CY 20181100003T CY 181100003 T CY181100003 T CY 181100003T CY 1119731 T1 CY1119731 T1 CY 1119731T1
Authority
CY
Cyprus
Prior art keywords
bital
procedure
production
acid producers
producers
Prior art date
Application number
CY20181100003T
Other languages
English (en)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Original Assignee
Intercept Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals, Inc. filed Critical Intercept Pharmaceuticals, Inc.
Publication of CY1119731T1 publication Critical patent/CY1119731T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Abstract

Η παρούσα εφεύρεση αναφέρεται σε διαδικασίες για την παρασκευή ενώσεων του τύπου I: ή ενός φαρμακευτικώς αποδεκτού άλατος ή επιδιαλυτώματος αυτών.
CY20181100003T 2012-10-26 2018-01-03 Διαδικασια για την παρασκευη παραγωγων χολικου οξεος CY1119731T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CY1119731T1 true CY1119731T1 (el) 2018-06-27

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100003T CY1119731T1 (el) 2012-10-26 2018-01-03 Διαδικασια για την παρασκευη παραγωγων χολικου οξεος

Country Status (21)

Country Link
US (2) US9777038B2 (el)
EP (1) EP2912013B1 (el)
JP (1) JP6272888B2 (el)
KR (1) KR102068381B1 (el)
CN (2) CN108250264A (el)
AU (1) AU2013334122B2 (el)
BR (1) BR112015009395A2 (el)
CA (1) CA2889592A1 (el)
CY (1) CY1119731T1 (el)
DK (1) DK2912013T3 (el)
ES (1) ES2655034T3 (el)
HK (2) HK1253301A1 (el)
HU (1) HUE036887T2 (el)
IL (1) IL238454B (el)
MX (1) MX361653B (el)
NO (1) NO2968302T3 (el)
NZ (2) NZ707389A (el)
PL (1) PL2912013T3 (el)
PT (1) PT2912013T (el)
SG (1) SG11201503247UA (el)
WO (1) WO2014066819A1 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2912013T3 (en) 2012-10-26 2018-01-15 Intercept Pharmaceuticals Inc Process for the preparation of bile acid derivatives
DK3626725T3 (da) * 2014-05-29 2023-02-27 Bar Pharmaceuticals S R L Cholan-derivater til anvendelse ved behandlingen og/eller forebyggelsen af fxr- og tgr5/gpbar1-medierede sygdomme
DK3221331T3 (da) 2014-11-19 2019-12-02 Nzp Uk Ltd 6-alkyl-7-hydroxy-4-en-3-on-steroider som mellemprodukter til fremstilling af steroide fxr-modulatorer
CA2968310A1 (en) 2014-11-19 2016-05-26 NZP UK Limited 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
CA2968301C (en) 2014-11-19 2023-05-16 NZP UK Limited 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
JP6735748B2 (ja) 2014-11-19 2020-08-05 エヌゼットピー ユーケー リミテッド ステロイドFXRモジュレーター製造のための中間体としての6α−アルキル−3,7−ジオン−ステロイド
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
JP7306791B2 (ja) 2015-02-06 2023-07-11 インターセプト ファーマシューティカルズ, インコーポレイテッド 併用療法のための医薬組成物
AU2016325619A1 (en) * 2015-09-24 2018-04-12 Intercept Pharmaceuticals, Inc. Methods and intermediates for the preparation bile acid derivatives
US10604545B2 (en) * 2015-11-06 2020-03-31 Intercept Pharmaceuticals, Inc. Methods for the preparation of obeticholic acid and derivatives thereof
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
IL262342B (en) 2016-04-13 2022-08-01 Intercept Pharmaceuticals Inc fxr agonist for use as a drug for the treatment or prevention of hepatocellular carcinoma
TW201738254A (zh) 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
US20200024299A1 (en) * 2016-09-30 2020-01-23 Intercept Pharmaceuticals, Inc. Crystalline forms of a bile acid derivative
MA49704A (fr) 2017-07-24 2021-03-31 Intercept Pharmaceuticals Inc Dérivés d'acide biliaire à marquage isotopique
EP3660030A4 (en) * 2017-07-26 2021-04-21 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. METHOD OF MANUFACTURING STEROID-DERIVATIVE FXR AGONISTS
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
CA3142358A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
AU2020363377A1 (en) 2019-10-07 2022-04-21 Kallyope, Inc. GPR119 agonists
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN116249536A (zh) 2020-09-18 2023-06-09 首尔大学校产学协力团 牛磺脱氧胆酸钠的批量生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
JP4021327B2 (ja) * 2001-03-12 2007-12-12 インターセプト ファーマスーティカル インコーポレイテッド Fxrに対する作用薬としてのステロイド
EP1568706A1 (en) * 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
US7932244B2 (en) * 2006-06-27 2011-04-26 Intercept Pharmaceuticals, Inc. Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
AU2009276507B2 (en) * 2008-07-30 2015-11-19 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
ES2592452T3 (es) * 2008-11-19 2016-11-30 Intercept Pharmaceuticals, Inc. Moduladores de TGR5 y métodos de uso de los mismos
DK2912013T3 (en) 2012-10-26 2018-01-15 Intercept Pharmaceuticals Inc Process for the preparation of bile acid derivatives

Also Published As

Publication number Publication date
MX361653B (es) 2018-12-13
KR20150074062A (ko) 2015-07-01
BR112015009395A2 (pt) 2017-07-04
CN105102425A (zh) 2015-11-25
JP2015533852A (ja) 2015-11-26
SG11201503247UA (en) 2015-06-29
CN108250264A (zh) 2018-07-06
PT2912013T (pt) 2018-01-03
US20150291653A1 (en) 2015-10-15
ES2655034T3 (es) 2018-02-16
CA2889592A1 (en) 2014-05-01
NZ707389A (en) 2018-08-31
DK2912013T3 (en) 2018-01-15
EP2912013A4 (en) 2016-06-01
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
KR102068381B1 (ko) 2020-01-20
IL238454B (en) 2018-11-29
PL2912013T3 (pl) 2018-05-30
CN105102425B (zh) 2018-04-10
EP2912013A1 (en) 2015-09-02
AU2013334122A1 (en) 2015-05-14
IL238454A0 (en) 2015-06-30
HK1253301A1 (zh) 2019-06-14
MX2015005286A (es) 2015-10-29
NZ745013A (en) 2019-08-30
US10202414B2 (en) 2019-02-12
WO2014066819A1 (en) 2014-05-01
US9777038B2 (en) 2017-10-03
NO2968302T3 (el) 2018-02-03
EP2912013B1 (en) 2017-10-11
US20180079776A1 (en) 2018-03-22
JP6272888B2 (ja) 2018-01-31
AU2013334122B2 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CY1119422T1 (el) Παραγωγα μπετουλινης
CY1118478T1 (el) Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
PH12016500169A1 (en) Polymorph of syk inhibitors
EA201590224A1 (ru) Имидазотриазинкарбонитрилы, используемые в качестве ингибиторов киназы
MD20180040A2 (ro) Inhibitori ai virusului hepatic C
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
EA201590319A1 (ru) Новые бициклические пиридиноны
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
CR20150271A (es) Peptidos como agonistas de oxitocina
CO6821935A2 (es) Derivados novedosos de cefalosporinas y cmposiciones farmacéuticas de estos
CY1118079T1 (el) Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
CR20150087A (es) Derivados de pirazol-carboxamida
EA201200123A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
EA201590594A1 (ru) Макролидные производные, их получение и их терапевтическое использование
EA201201385A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
IN2014DN07498A (el)
EA201300281A2 (ru) Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
EA201690908A1 (ru) Пиразолопиримидиновые соединения
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.